Regular assessment of ADAMTS13 activity and EASIX should be considered part of post-remission surveillance, especially during situations that may trigger clinical relapse, such as infections, pregnancy, or systemic inflammatory episodes. The gene discussed is ADAMTS13; the disease is infection.